Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 552

1.

Effects of nitric oxide synthase inhibition on dexmedetomidine-induced vasoconstriction in healthy human volunteers.

Snapir A, Talke P, Posti J, Huiku M, Kentala E, Scheinin M.

Br J Anaesth. 2009 Jan;102(1):38-46. doi: 10.1093/bja/aen316. Epub 2008 Nov 5.

PMID:
18987056
2.

The nitric oxide synthase inhibitor L-NMMA potentiates noradrenaline-induced vasoconstriction: effects of the alpha2-receptor antagonist yohimbine.

Bruck H, Gössl M, Spitthöver R, Schäfers RF, Kohnle M, Philipp T, Wenzel RR.

J Hypertens. 2001 May;19(5):907-11.

PMID:
11393674
3.

Systemically administered alpha2-agonist-induced peripheral vasoconstriction in humans.

Talke P, Lobo E, Brown R.

Anesthesiology. 2003 Jul;99(1):65-70.

PMID:
12826844
4.

Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.

Lembo G, Iaccarino G, Vecchione C, Barbato E, Izzo R, Fontana D, Trimarco B.

J Clin Invest. 1997 Oct 15;100(8):2007-14.

5.

In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.

Pickkers P, Dorresteijn MJ, Bouw MP, van der Hoeven JG, Smits P.

Circulation. 2006 Aug 1;114(5):414-21. Epub 2006 Jul 24.

6.

Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age.

Lyons D, Roy S, Patel M, Benjamin N, Swift CG.

Clin Sci (Lond). 1997 Dec;93(6):519-25.

PMID:
9497788
7.

Intracarotid infusion of the nitric oxide synthase inhibitor, L-NMMA, modestly decreases cerebral blood flow in human subjects.

Joshi S, Young WL, Duong DH, Ostapkovich ND, Aagaard BD, Hashimoto T, Pile-Spellman J.

Anesthesiology. 2000 Sep;93(3):699-707.

PMID:
10969303
8.

Sedative but not analgesic alpha2 agonist tolerance is blocked by NMDA receptor and nitric oxide synthase inhibitors.

Davies MF, Reid K, Guo TZ, Agashe GS, Amin YK, Maze M.

Anesthesiology. 2001 Jul;95(1):184-91.

PMID:
11465557
10.

beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine.

Schlaich MP, Ahlers BA, Parnell MM, Kaye DM.

J Hypertens. 2004 Oct;22(10):1917-25.

PMID:
15361763
11.
12.

Inhibition of nitric oxide metabolism enhances the hypnotic-anesthetic action of the alpha2-adrenoceptor agonist dexmedetomidine in vivo.

Tonner PH, Scholz J, Schlamp N, Schulte am Esch J.

J Neurosurg Anesthesiol. 1999 Jan;11(1):37-41.

PMID:
9890384
13.

Forearm vasoconstriction in response to noradrenaline and NG-monomethyl-L-arginine in essential hypertension.

Kneale BJ, Chowienczyk PJ, Brett SE, Cockcroft JR, Ritter JM.

Clin Sci (Lond). 1999 Sep;97(3):277-82.

PMID:
10464052
14.

Haemodynamic effects of inhibition of nitric oxide synthase and of L-arginine at rest and during exercise.

Brett SE, Cockcroft JR, Mant TG, Ritter JM, Chowienczyk PJ.

J Hypertens. 1998 Apr;16(4):429-35.

PMID:
9797188
15.

Influence of indomethacin and L-NMMA on vascular tone and angiotensin II-induced vasoconstriction in the human forearm.

Baan J Jr, Chang PC, Vermeij P, Pfaffendorf M, van Zwieten PA.

Blood Press. 1997 Sep;6(5):279-85.

PMID:
9359998
16.
17.

Comparison of forearm vasodilatation to substance P and acetylcholine: contribution of nitric oxide.

Newby DE, Boon NA, Webb DJ.

Clin Sci (Lond). 1997 Feb;92(2):133-8.

PMID:
9059313
18.
19.

Interaction between cholinergic and nitrergic vasodilation: a novel mechanism of blood pressure control.

Lepori M, Sartori C, Duplain H, Nicod P, Scherrer U.

Cardiovasc Res. 2001 Sep;51(4):767-72.

PMID:
11530110
20.

Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins.

Schindler C, Leuschner S, Schwanebeck U, Kirch W.

J Clin Pharmacol. 2012 Jun;52(6):859-69. doi: 10.1177/0091270011406277. Epub 2011 May 12.

PMID:
21566204

Supplemental Content

Support Center